Proteome Sciences Plc (PRM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -140 | 272 | -68 | -80 | 37 |
| Other Working Capital | 580 | 727 | 386 | 334 | 392 |
| Other Operating Activity | -5,209 | -4,770 | -5,193 | -3,528 | -1,983 |
| Operating Cash Flow | $-4,769 | $-3,771 | $-4,875 | $-3,274 | $-1,554 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -181 | -196 | 3 | -51 | -473 |
| Net Acquisitions | N/A | -1,926 | N/A | 3,638 | -79 |
| Sale Of Investment | N/A | N/A | 1 | 3 | N/A |
| Other Investing Activity | -100 | 2,995 | -1,446 | -2,548 | 2,000 |
| Investing Cash Flow | $-281 | $873 | $-1,442 | $1,042 | $1,448 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 84 | 13 | N/A | 48 | N/A |
| Common Stock Issued | 5,027 | 2,179 | 6,597 | 2,616 | N/A |
| Other Financing Activity | 0 | -33 | -67 | -83 | -52 |
| Financing Cash Flow | $5,111 | $2,159 | $6,530 | $2,581 | $-52 |
| Exchange Rate Effect | N/A | N/A | N/A | -86 | -65 |
| Beginning Cash Position | 2,526 | 3,165 | 5,913 | 3,926 | 1,202 |
| End Cash Position | 61 | -739 | 213 | 349 | 979 |
| Net Cash Flow | $61 | $-739 | $213 | $349 | $-158 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,769 | -3,771 | -4,875 | -3,274 | -1,554 |
| Capital Expenditure | -188 | -196 | -4 | -61 | -488 |
| Free Cash Flow | -4,957 | -3,967 | -4,879 | -3,335 | -2,042 |